SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-028695
Filing Date
2024-07-22
Accepted
2024-07-22 17:04:50
Documents
3
Period of Report
2024-07-22

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 164300
2 proxycard_001.jpg GRAPHIC 401205
3 proxycard_002.jpg GRAPHIC 267406
  Complete submission text file 0001493152-24-028695.txt   1086339
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40874 | Film No.: 241132167
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)